Treace John T. - 21 Nov 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Executive Offer, Director, 10%+ Owner
Signature
/s/ Lisa Taylor as Attorney-in-fact for John T. Treace
Issuer symbol
TMCI
Transactions as of
21 Nov 2022
Net transactions value
+$327,405
Form type
4
Filing time
21 Nov 2022, 17:27:07 UTC
Previous filing
17 Nov 2022
Next filing
10 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Purchase $327,405 +15,000 +0.27% $21.83 5,541,455 21 Nov 2022 Direct F1, F2
holding TMCI Common Stock 1,605,000 21 Nov 2022 By Spouse F3
holding TMCI Common Stock 1,471,250 21 Nov 2022 By Spouse as cotrustee of a trust dated Sept 30, 2020 F3
holding TMCI Common Stock 1,839,063 21 Nov 2022 As Trustee of a trust dated Sept 25, 2020 F4
holding TMCI Common Stock 408,816 21 Nov 2022 As Co-Trustee of a trust dated July 29, 2021 F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $21.5500 to $21.9700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
F2 Includes 33,875 restricted stock units.
F3 The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
F4 The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as Trustee or Co-Trustee.